Virbac Stock Rebounds by 2.75% to €355, Defending its Key Moving Average
The veterinary laboratory in Carros gains 2.75% to €355 in mid-morning trading, in a rising Parisian market. The SBF 120 index is up by 0.75% at the same time. Over a year, the stock maintains a lead of 13.96%.
The Stock Moves Above its MM200 but Struggles Below its 20-Day Average
Virbac stock approaches its 50-day moving average (€356.23), while remaining 2.52% below its MM20 (€364.18). Today's rebound allows the price to stay above the MM200 at €347.18, a long-term trend marker that has been preserved for several sessions. The RSI at 41 remains neutral, showing no signs of exhaustion. The price is in the lower part of the Bollinger Bands, at 34% of the range, between a lower bound of €336.35 and an upper bound of €392.00. The support at €339.00, close to this lower bound, was not tested during the session. The one-month volatility stands at 7.35, consistent with levels observed in recent weeks on the stock. Today's rise is part of a collective movement on the SBF 120, where Atos, Capgemini, and Exosens lead the gains.
Focus on the General Assembly on June 26 and the Q2 Revenue Release in July
Following the publication of the first quarter revenue on April 20, amounting to €384 million (+7.7% at constant scope and exchange rates), the financial calendar points to the next events being the ordinary general assembly on June 26, 2026, followed by the second quarter revenue release on July 20, 2026. The next bullish technical milestone identified in the indicators is the resistance at €384.00, which the price has not revisited for several sessions.
